![PDF) Potential therapeutic use of IL-37: a key suppressor of innate immunity and allergic immune responses mediated by mast cells PDF) Potential therapeutic use of IL-37: a key suppressor of innate immunity and allergic immune responses mediated by mast cells](https://www.researchgate.net/profile/E-Spinas-2/publication/318705857/figure/fig3/AS:962703921262593@1606537909510/IL-37-binding-IL-18Ra-inhibits-several-inflammatory-pathways-including-allergy-acute_Q320.jpg)
PDF) Potential therapeutic use of IL-37: a key suppressor of innate immunity and allergic immune responses mediated by mast cells
![PDF) Potential therapeutic use of IL-37: a key suppressor of innate immunity and allergic immune responses mediated by mast cells PDF) Potential therapeutic use of IL-37: a key suppressor of innate immunity and allergic immune responses mediated by mast cells](https://www.researchgate.net/profile/E-Spinas-2/publication/318705857/figure/fig2/AS:962703921262592@1606537909263/Mast-cell-generation-from-hematopoietic-stem-cells-activated-by-antigen-leads-to-cytokine_Q320.jpg)
PDF) Potential therapeutic use of IL-37: a key suppressor of innate immunity and allergic immune responses mediated by mast cells
![PDF) Construction of Ultradense Linkage Maps with Lep-MAP2: Stickleback F2 Recombinant Crosses as an Example PDF) Construction of Ultradense Linkage Maps with Lep-MAP2: Stickleback F2 Recombinant Crosses as an Example](https://i1.rgstatic.net/publication/286921481_Construction_of_Ultradense_Linkage_Maps_with_Lep-MAP2_Stickleback_F2_Recombinant_Crosses_as_an_Example/links/5f50623a299bf13a31991730/largepreview.png)